{"description":"Documents matching 'security specific instructions submitting these'","count":10000,"total_pages":50,"next_page_url":"https://www.federalregister.gov/api/v1/documents?conditions%5Bterm%5D=security+specific+instructions+submitting+these&format=json&page=2","results":[{"title":"Common Instructions and Information for Applicants to Department of Education Discretionary Grant Programs","type":"Notice","abstract":"On December 23, 2024, the Department of Education (Department) published a set of common instructions for applicants seeking funds under a Department discretionary grant competition. In this notice, the Department is publishing a revised version of the common instructions that supersedes the version published on December 23, 2024.","document_number":"2025-16571","html_url":"https://www.federalregister.gov/documents/2025/08/29/2025-16571/common-instructions-and-information-for-applicants-to-department-of-education-discretionary-grant","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-08-29/pdf/2025-16571.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-16571.pdf?1756385138","publication_date":"2025-08-29","agencies":[{"raw_name":"DEPARTMENT OF EDUCATION","name":"Education Department","id":126,"url":"https://www.federalregister.gov/agencies/education-department","json_url":"https://www.federalregister.gov/api/v1/agencies/126","parent_id":null,"slug":"education-department"}],"excerpts":"\n This document is a centralized and up-to-date set of <span class=\"match\">instructions</span> for applying to the Department's discretionary grant programs. Notices inviting applications (NIAs) will reference this document instead of providing this series of <span class=\"match\">instructions</span> within each NIA. If in the rare circumstance exceptions to these <span class=\"match\">instructions</span> are necessary, they will be noted in an individual competition NIA.\n \n \n Revised Common <span class=\"match\">Instructions</span>: \n The Department is making changes to the revised common <span class=\"match\">instructions</span> for applicants that were published in the \n Federal Register"},{"title":"Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I","type":"Rule","abstract":"The Drug Enforcement Administration places seven fentanyl- related substances, as identified in this final rule, including their isomers, esters, ethers, salts and salts of isomers, esters and ethers in schedule I of the Controlled Substances Act. The regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle these seven specific controlled substances will continue to apply as a result of this action.","document_number":"2025-18103","html_url":"https://www.federalregister.gov/documents/2025/09/18/2025-18103/schedules-of-controlled-substances-placement-of-seven-specific-fentanyl-related-substances-in","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-09-18/pdf/2025-18103.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-18103.pdf?1758113117","publication_date":"2025-09-18","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"or before January 29, 2025. DEA did not receive a hearing request. The NPRM also provided an opportunity for interested persons to <span class=\"match\">submit</span> comments on the proposed rule on or before January 29, 2025. DEA did not receive any comment on the proposed rule to control these seven <span class=\"match\">specific</span> fentanyl-related substances in schedule I of the CSA.\n \n \n \n 9 \n  \n See \n Schedules of Controlled Substances: Placement of Seven <span class=\"match\">Specific</span> Fentanyl-Related Substances in Schedule I, 89 FR 106384 (Dec. 30, 2024).\n \n \n Scheduling Conclusion \n \n After consideration of the"},{"title":"Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability","type":"Notice","abstract":"The Food and Drug Administration (FDA or Agency) is announcing the availability of additional draft and revised draft product-specific guidances. The draft guidances provide product-specific recommendations on, among other things, the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs). In the Federal Register of June 11, 2010, FDA announced the availability of a guidance for industry entitled \"Bioequivalence Recommendations for Specific Products\" that explained the process that would be used to make product-specific guidances available to the public on FDA's website. The draft guidances identified in this notice were developed using the process described in that guidance.","document_number":"2026-10277","html_url":"https://www.federalregister.gov/documents/2026/05/22/2026-10277/product-specific-guidances-draft-and-revised-draft-guidances-for-industry-availability","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-05-22/pdf/2026-10277.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-10277.pdf?1779367511","publication_date":"2026-05-22","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"\n \n DATES: \n <span class=\"match\">Submit</span> either electronic or written comments on these draft guidances by July 21, 2026 to ensure that the Agency considers your comment on these draft guidances before it begins work on the final version of these guidances. \n \n \n ADDRESSES: \n You may <span class=\"match\">submit</span> comments on any guidance at any time as follows: \n \n Electronic Submissions \n <span class=\"match\">Submit</span> electronic comments in the following way: \n \n • \n Federal eRulemaking Portal: \n \n https://www.regulations.gov. \n Follow the <span class=\"match\">instructions</span> for <span class=\"match\">submitting</span> comments. Comments <span class=\"match\">submitted</span> electronically"},{"title":"Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability","type":"Notice","abstract":"The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of additional draft and revised draft product-specific guidances. The draft guidances provide product-specific recommendations on, among other things, the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs). In the Federal Register of June 11, 2010, FDA announced the availability of a guidance for industry entitled \"Bioequivalence Recommendations for Specific Products\" that explained the process that would be used to make product-specific guidances available to the public on FDA's website. The draft guidances identified in this notice were developed using the process described in that guidance.","document_number":"2026-03963","html_url":"https://www.federalregister.gov/documents/2026/02/27/2026-03963/product-specific-guidances-draft-and-revised-draft-guidances-for-industry-availability","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-02-27/pdf/2026-03963.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-03963.pdf?1772113515","publication_date":"2026-02-27","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"\n \n \n \n DATES: \n <span class=\"match\">Submit</span> either electronic or written comments on the draft guidance by April 28, 2026 to ensure that the Agency considers your comment on this draft guidance before it begins work on the final version of the guidance. \n \n \n ADDRESSES: \n You may <span class=\"match\">submit</span> comments on any guidance at any time as follows: \n \n Electronic Submissions \n <span class=\"match\">Submit</span> electronic comments in the following way: \n \n • \n Federal eRulemaking Portal: \n \n https://www.regulations.gov. \n Follow the <span class=\"match\">instructions</span> for <span class=\"match\">submitting</span> comments. Comments <span class=\"match\">submitted</span> electronically, including"},{"title":"Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability","type":"Notice","abstract":"The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of additional draft and revised draft product-specific guidances. The draft guidances provide product- specific recommendations on, among other things, the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs). In the Federal Register of June 11, 2010, FDA announced the availability of a guidance for industry entitled \"Bioequivalence Recommendations for Specific Products\" that explained the process that would be used to make product-specific guidances available to the public on FDA's website. The draft guidances identified in this notice were developed using the process described in that guidance.","document_number":"2025-22131","html_url":"https://www.federalregister.gov/documents/2025/12/05/2025-22131/product-specific-guidances-draft-and-revised-draft-guidances-for-industry-availability","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-12-05/pdf/2025-22131.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-22131.pdf?1764855937","publication_date":"2025-12-05","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"guidance.\n \n \n \n DATES: \n <span class=\"match\">Submit</span> either electronic or written comments on the draft guidance by February 3, 2026 to ensure that the Agency considers your comment on this draft guidance before it begins work on the final version of the guidance. \n \n \n ADDRESSES: \n You may <span class=\"match\">submit</span> comments on any guidance at any time as follows: \n \n Electronic Submissions \n <span class=\"match\">Submit</span> electronic comments in the following way: \n \n • \n Federal eRulemaking Portal: https://www.regulations.gov. \n Follow the <span class=\"match\">instructions</span> for <span class=\"match\">submitting</span> comments. Comments <span class=\"match\">submitted</span> electronically, including"},{"title":"Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability","type":"Notice","abstract":"The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of additional draft and revised draft product-specific guidances. The draft guidances provide product- specific recommendations on, among other things, the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs). In the Federal Register of June 11, 2010, FDA announced the availability of a guidance for industry entitled \"Bioequivalence Recommendations for Specific Products\" that explained the process that would be used to make product-specific guidances available to the public on FDA's website. The draft guidances identified in this notice were developed using the process described in that guidance.","document_number":"2025-20548","html_url":"https://www.federalregister.gov/documents/2025/11/21/2025-20548/product-specific-guidances-draft-and-revised-draft-guidances-for-industry-availability","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-11-21/pdf/2025-20548.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-20548.pdf?1763646316","publication_date":"2025-11-21","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"\n \n \n \n DATES: \n <span class=\"match\">Submit</span> either electronic or written comments on the draft guidance by January 20, 2026 to ensure that the Agency considers your comment on this draft guidance before it begins work on the final version of the guidance. \n \n \n ADDRESSES: \n You may <span class=\"match\">submit</span> comments on any guidance at any time as follows: \n \n Electronic Submissions \n <span class=\"match\">Submit</span> electronic comments in the following way: \n \n • \n Federal eRulemaking Portal: https://www.regulations.gov \n . Follow the <span class=\"match\">instructions</span> for <span class=\"match\">submitting</span> comments. Comments <span class=\"match\">submitted</span> electronically, including"},{"title":"Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability","type":"Notice","abstract":"The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of additional draft and revised draft product-specific guidances. The draft guidances provide product- specific recommendations on, among other things, the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs). In the Federal Register of June 11, 2010, FDA announced the availability of a guidance for industry entitled \"Bioequivalence Recommendations for Specific Products\" that explained the process that would be used to make product-specific guidances available to the public on FDA's website. The draft guidances identified in this notice were developed using the process described in that guidance.","document_number":"2025-19345","html_url":"https://www.federalregister.gov/documents/2025/10/02/2025-19345/product-specific-guidances-draft-and-revised-draft-guidances-for-industry-availability","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-10-02/pdf/2025-19345.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-19345.pdf?1759322728","publication_date":"2025-10-02","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"\n \n \n DATES: \n <span class=\"match\">Submit</span> either electronic or written comments on the draft guidance by December 1, 2025 to ensure that the Agency considers your comment on this draft guidance before it begins work on the final version of the guidance. \n \n \n \n ADDRESSES: \n You may <span class=\"match\">submit</span> comments on any guidance at any time as follows: \n \n Electronic Submissions \n <span class=\"match\">Submit</span> electronic comments in the following way: \n \n • \n Federal eRulemaking Portal: \n \n https://www.regulations.gov. \n Follow the <span class=\"match\">instructions</span> for <span class=\"match\">submitting</span> comments. Comments <span class=\"match\">submitted</span> electronically"},{"title":"Notice of Request for Public Comments on Section 232 National Security Investigation of Anthracite Coal","type":"Notice","abstract":"On June 29, 2026, the Secretary of Commerce initiated an investigation to determine the effects on the national security of imports of anthracite coal. This investigation has been initiated under section 232 of the Trade Expansion Act of 1962, as amended (Section 232). Interested parties are invited to submit written comments, data, analyses, or other information pertinent to the investigation to the Department of Commerce's (Department) Bureau of Industry and Security (BIS), Office of Strategic Industries and Economic Security. This notice identifies issues on which the Department is especially interested in obtaining the public's views.","document_number":"2026-13663","html_url":"https://www.federalregister.gov/documents/2026/07/07/2026-13663/notice-of-request-for-public-comments-on-section-232-national-security-investigation-of-anthracite","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-07-07/pdf/2026-13663.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-13663.pdf?1783005309","publication_date":"2026-07-07","agencies":[{"raw_name":"DEPARTMENT OF COMMERCE","name":"Commerce Department","id":54,"url":"https://www.federalregister.gov/agencies/commerce-department","json_url":"https://www.federalregister.gov/api/v1/agencies/54","parent_id":null,"slug":"commerce-department"},{"raw_name":"Bureau of Industry and Security","name":"Industry and Security Bureau","id":241,"url":"https://www.federalregister.gov/agencies/industry-and-security-bureau","json_url":"https://www.federalregister.gov/api/v1/agencies/241","parent_id":54,"slug":"industry-and-security-bureau"}],"excerpts":"views. \n \n \n DATES: \n Comments may be <span class=\"match\">submitted</span> at any time but must be received by July 21, 2026. \n \n \n ADDRESSES: \n \n Comments on this notice may be <span class=\"match\">submitted</span> to the Federal rulemaking portal at: \n www.regulations.gov. \n The \n regulations.gov \n ID for this notice is BIS-2026-0298. Please refer to XRIN 0694-XC165 in all comments.\n \n All filers using the portal should use the name of the person or entity <span class=\"match\">submitting</span> the comments as the name of their files, in accordance with the <span class=\"match\">instructions</span> below. Anyone <span class=\"match\">submitting</span> business confidential information"},{"title":"Common Instructions for Applicants to Department of Education Discretionary Grant Programs","type":"Notice","abstract":"On December 7, 2022, the Department of Education (Department) published a revised set of common instructions for applicants seeking funds under a Department discretionary grant competition. In this notice, the Department is publishing a revised version of the common instructions that supersedes the version published on December 7, 2022.","document_number":"2024-30488","html_url":"https://www.federalregister.gov/documents/2024/12/23/2024-30488/common-instructions-for-applicants-to-department-of-education-discretionary-grant-programs","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-12-23/pdf/2024-30488.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-30488.pdf?1734702325","publication_date":"2024-12-23","agencies":[{"raw_name":"DEPARTMENT OF EDUCATION","name":"Education Department","id":126,"url":"https://www.federalregister.gov/agencies/education-department","json_url":"https://www.federalregister.gov/api/v1/agencies/126","parent_id":null,"slug":"education-department"}],"excerpts":"This document is a centralized and up-to-date set of <span class=\"match\">instructions</span> for applying to the Department's discretionary grant programs. Notices inviting applications (NIAs) will reference this document instead of providing this series of <span class=\"match\">instructions</span> within each NIA. If in the rare circumstance exceptions to these <span class=\"match\">instructions</span> are necessary, they will be noted in an individual competition NIA.\n \n \n Revised Common <span class=\"match\">Instructions</span>: \n \n \n The Department is making changes to the revised common <span class=\"match\">instructions</span> for applicants that were published in the \n Federal Register"},{"title":"Modernizing Security Requirements","type":"Proposed Rule","abstract":"The U.S. Nuclear Regulatory Commission (NRC) is proposing to revise its regulations to modernize security and fitness-for-duty requirements to enhance efficiency, consistent with Executive Order 14300, \"Ordering the Reform of the Nuclear Regulatory Commission.\" The proposed revisions are intended to reduce regulatory burden, where appropriate, while continuing to provide reasonable assurance that safety and security will be adequately maintained at NRC-licensed facilities.","document_number":"2026-12989","html_url":"https://www.federalregister.gov/documents/2026/06/26/2026-12989/modernizing-security-requirements","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-06-26/pdf/2026-12989.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-12989.pdf?1782391523","publication_date":"2026-06-26","agencies":[{"raw_name":"NUCLEAR REGULATORY COMMISSION","name":"Nuclear Regulatory Commission","id":383,"url":"https://www.federalregister.gov/agencies/nuclear-regulatory-commission","json_url":"https://www.federalregister.gov/api/v1/agencies/383","parent_id":null,"slug":"nuclear-regulatory-commission"}],"excerpts":"Obtaining Information and <span class=\"match\">Submitting</span> Comments \n A. Obtaining Information \n B. <span class=\"match\">Submitting</span> Comments \n II. Executive Order 14300: Ordering the Reform of the Nuclear Regulatory Commission \n III. Background \n IV. Discussion \n A. Fitness for Duty Programs (Part 26) \n B. <span class=\"match\">Security</span> Requirements for Independent Spent Fuel Storage Installations (ISFSIs) (Parts 72 and 73) \n C. Physical <span class=\"match\">Security</span> Requirements (Part 73) \n D. Facility <span class=\"match\">Security</span> Clearance and Safeguarding of National <span class=\"match\">Security</span> Information and Restricted Data (Part 95) \n V. <span class=\"match\">Specific</span> Requests for Comments"},{"title":"Product-Specific Guidance on Estradiol; Draft Guidance for Industry; Availability","type":"Notice","abstract":"The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a new draft guidance for industry entitled \"Draft Guidance on Estradiol\" and a revised draft guidance for industry entitled \"Draft Guidance on Estradiol.\" The new draft guidance and the revised draft guidance, when finalized, will provide product-specific recommendations on, among other things, the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs) for estradiol vaginal inserts and estradiol vaginal tablets.","document_number":"2025-22249","html_url":"https://www.federalregister.gov/documents/2025/12/08/2025-22249/product-specific-guidance-on-estradiol-draft-guidance-for-industry-availability","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-12-08/pdf/2025-22249.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-22249.pdf?1764942320","publication_date":"2025-12-08","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"Written/Paper Submissions \n <span class=\"match\">Submit</span> written/paper submissions as follows: \n \n • \n Mail/Hand Delivery/Courier (for written/paper submissions): \n Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.\n \n • For written/paper comments <span class=\"match\">submitted</span> to the Dockets Management Staff, FDA will post your comment, as well as any attachments, except for information <span class=\"match\">submitted</span>, marked and identified, as confidential, if <span class=\"match\">submitted</span> as detailed in “<span class=\"match\">Instructions</span>.” \n \n <span class=\"match\">Instructions</span>: \n All submissions received"},{"title":"Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability","type":"Notice","abstract":"The Food and Drug Administration (FDA or Agency) is announcing the availability of additional draft and revised draft product-specific guidances. The draft guidances provide product-specific recommendations on, among other things, the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs). In the Federal Register of June 11, 2010, FDA announced the availability of a guidance for industry entitled \"Bioequivalence Recommendations for Specific Products\" that explained the process that would be used to make product-specific guidances available to the public on FDA's website. The draft guidances identified in this notice were developed using the process described in that guidance.","document_number":"2025-09068","html_url":"https://www.federalregister.gov/documents/2025/05/21/2025-09068/product-specific-guidances-draft-and-revised-draft-guidances-for-industry-availability","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-05-21/pdf/2025-09068.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-09068.pdf?1747745113","publication_date":"2025-05-21","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"guidance.\n \n \n \n DATES: \n <span class=\"match\">Submit</span> either electronic or written comments on the draft guidance by July 21, 2025 to ensure that the Agency considers your comment on this draft guidance before it begins work on the final version of the guidance. \n \n \n ADDRESSES: \n You may <span class=\"match\">submit</span> comments on any guidance at any time as follows: \n \n Electronic Submissions \n <span class=\"match\">Submit</span> electronic comments in the following way: \n \n • \n Federal eRulemaking Portal: https://www.regulations.gov. \n Follow the <span class=\"match\">instructions</span> for <span class=\"match\">submitting</span> comments. Comments <span class=\"match\">submitted</span> electronically, including"},{"title":"Notice of Request for Public Comments on Section 232 National Security Investigation of Imports of Robotics and Industrial Machinery","type":"Notice","abstract":"On September 2, 2025, the Secretary of Commerce initiated an investigation to determine the effects on the national security of imports of robotics and industrial machinery. This investigation has been initiated under section 232 of the Trade Expansion Act of 1962, as amended (Section 232). Interested parties are invited to submit written comments, data, analyses, or other information pertinent to the investigation to the Department of Commerce's (Department) Bureau of Industry and Security (BIS), Office of Strategic Industries and Economic Security. This notice identifies issues on which the Department is especially interested in obtaining the public's views.","document_number":"2025-18749","html_url":"https://www.federalregister.gov/documents/2025/09/26/2025-18749/notice-of-request-for-public-comments-on-section-232-national-security-investigation-of-imports-of","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-09-26/pdf/2025-18749.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-18749.pdf?1758744910","publication_date":"2025-09-26","agencies":[{"raw_name":"DEPARTMENT OF COMMERCE","name":"Commerce Department","id":54,"url":"https://www.federalregister.gov/agencies/commerce-department","json_url":"https://www.federalregister.gov/api/v1/agencies/54","parent_id":null,"slug":"commerce-department"},{"raw_name":"Bureau of Industry and Security","name":"Industry and Security Bureau","id":241,"url":"https://www.federalregister.gov/agencies/industry-and-security-bureau","json_url":"https://www.federalregister.gov/api/v1/agencies/241","parent_id":54,"slug":"industry-and-security-bureau"}],"excerpts":"\n \n \n DATES: \n Comments may be <span class=\"match\">submitted</span> at any time but must be received by October 17, 2025. \n \n \n ADDRESSES: \n \n Comments on this notice may be <span class=\"match\">submitted</span> to the Federal rulemaking portal at: \n www.regulations.gov. \n The \n regulations.gov \n ID for this notice is BIS-2025-0257. Please refer to XRIN 0694-XC138 in all comments.\n \n \n All filers using the portal should use the name of the person or entity <span class=\"match\">submitting</span> the comments as the name of their files, in accordance with the <span class=\"match\">instructions</span> below. Anyone <span class=\"match\">submitting</span> business confidential information"},{"title":"Revision of Agency Information Collection Activity Under OMB Review: Pipeline Corporate Security Reviews and TSA Security Directive Pipeline-2021-02 Series","type":"Notice","abstract":"This notice announces that the Transportation Security Administration (TSA) has forwarded the Information Collection Request (ICR), Office of Management and Budget (OMB) control number 1652-0056, abstracted below, to OMB for review and approval of a revision of the currently approved collection under the Paperwork Reduction Act (PRA). The ICR describes the nature of the information collection and its expected burden. The collection allows TSA to assess the current security practices in the pipeline industry through TSA's Pipeline Corporate Security Review (CSR) program and allows for the continuation of mandatory cybersecurity requirements under the TSA Security Directive (SD) Pipeline-2021-02 series.","document_number":"2025-24198","html_url":"https://www.federalregister.gov/documents/2026/01/02/2025-24198/revision-of-agency-information-collection-activity-under-omb-review-pipeline-corporate-security","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-01-02/pdf/2025-24198.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-24198.pdf?1767188716","publication_date":"2026-01-02","agencies":[{"raw_name":"DEPARTMENT OF HOMELAND SECURITY","name":"Homeland Security Department","id":227,"url":"https://www.federalregister.gov/agencies/homeland-security-department","json_url":"https://www.federalregister.gov/api/v1/agencies/227","parent_id":null,"slug":"homeland-security-department"},{"raw_name":"Transportation Security Administration","name":"Transportation Security Administration","id":494,"url":"https://www.federalregister.gov/agencies/transportation-security-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/494","parent_id":227,"slug":"transportation-security-administration"}],"excerpts":"Pipeline Corporate <span class=\"match\">Security</span> Reviews and TSA <span class=\"match\">Security</span> Directive Pipeline-2021-02 series.\n \n \n Type of Request: \n Revision of a currently approved collection.\n \n \n OMB Control Number: \n 1652-0056.\n \n \n Forms(s): \n Pipeline CSR Protocol Form and documents <span class=\"match\">submitted</span> to TSA pursuant to the requirements in the <span class=\"match\">Security</span> Directive.\n \n \n Affected Public: \n Hazardous Liquids and Natural Gas Pipeline Industry.\n \n \n Abstract: \n Under the Aviation and Transportation <span class=\"match\">Security</span> Act \n 1 \n \n and delegated authority from the Secretary of Homeland <span class=\"match\">Security</span>, TSA has broad"},{"title":"Agency Forms Submitted for OMB Review, Request for Comments","type":"Notice","abstract":"In accordance with the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35), the Railroad Retirement Board (RRB) is forwarding an Information Collection Request (ICR) to the Office of Information and Regulatory Affairs (OIRA), Office of Management and Budget (OMB). Our ICR describes the information we seek to collect from the public. Review and approval by OIRA ensures that we impose appropriate paperwork burdens. The RRB invites comments on the proposed collections of information to determine (1) the practical utility of the collections; (2) the accuracy of the estimated burden of the collections; (3) ways to enhance the quality, utility, and clarity of the information that is the subject of collection; and (4) ways to minimize the burden of collections on respondents, including the use of automated collection techniques or other forms of information technology. Comments to the RRB or OIRA must contain the OMB control number of the ICR. For proper consideration of your comments, it is best if the RRB and OIRA receive them within 30 days of the publication date. 1. Title and purpose of information collection: Employer Reporting; 3220-0005. Under Section 9 of the Railroad Retirement Act (RRA), and Section 6 of the Railroad Unemployment Insurance Act (RUIA), railroad employers are required to submit reports of employee service and compensation to the RRB as needed for administering the RRA and RUIA. To pay benefits due on a deceased employee's earnings records or determine entitlement to, and amount of annuity applied for, it is necessary at times to obtain from railroad employers current (lag) service and compensation not yet reported to the RRB through the annual reporting process. The reporting requirements are specified in 20 CFR 209.6 and 209.7. The RRB currently utilizes the following forms to collect information to obtain the required lag service and related information from railroad employers: Form AA-12, Notice of Death and Request for Service Needed for Eligibility, Form G-88A.1 (or its internet equivalent, Form G-88A.1 (Internet)), Request for Verification of Date Last Worked, and Form G-88A.2 (or its internet equivalent, Form G-88A.2 (Internet)), Notice of Retirement and Request for Service Needed for Eligibility. Form AA-12 obtains a report of lag service and compensation from the last railroad employer of a deceased employee. This report covers the lag period between the date of the latest record of employment processed by the RRB and the date an employee last worked, the date of death or the date the employee may have been entitled to benefits under the Social Security Act. The information is used by the RRB to determine benefits due on the deceased employee's earnings record. Form G-88A.1 is sent by the RRB via a computer- generated listing or transmitted electronically via the RRB's Employer Reporting System (ERS) to employers. ERS consists of a series of screens with completion instructions and collects essentially the same information as the approved manual version. Form G-88A.1 is used for the specific purpose of verifying information previously provided to the RRB regarding the date last worked by an employee. If the information is correct, the employer need not reply. If the information is incorrect, the employer is asked to provide corrected information. Form G-88A.2 is used by the RRB to secure lag service and compensation information when it is needed to determine benefit eligibility. In addition, 20 CFR 209.12(b) requires all railroad employers to furnish the RRB with the home addresses of all employees hired within the last year (new-hires). Form BA-6a, Form BA-6 Address Report (or its internet equivalent, Form BA-6a (Internet)) is used by the RRB to obtain home address information of employees from railroad employers who do not have the home address information computerized and who submit the information in a paper format. The form also serves as an instruction sheet to railroad employers who submit the information electronically by CD-ROM. Completion of the forms is mandatory. Multiple responses may be filed by respondent. Previous Requests for Comments: The RRB has already published the initial 60-day notice (90 FR 52714 on November 21, 2025) required by 44 U.S.C. 3506(c)(2). That request elicited no comments.","document_number":"2026-01024","html_url":"https://www.federalregister.gov/documents/2026/01/21/2026-01024/agency-forms-submitted-for-omb-review-request-for-comments","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-01-21/pdf/2026-01024.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-01024.pdf?1768916711","publication_date":"2026-01-21","agencies":[{"raw_name":"RAILROAD RETIREMENT BOARD","name":"Railroad Retirement Board","id":444,"url":"https://www.federalregister.gov/agencies/railroad-retirement-board","json_url":"https://www.federalregister.gov/api/v1/agencies/444","parent_id":null,"slug":"railroad-retirement-board"}],"excerpts":"have been entitled to benefits under the Social <span class=\"match\">Security</span> Act. The information is used by the RRB to determine benefits due on the deceased employee's earnings record. Form G-88A.1 is sent by the RRB via a computer-generated listing or transmitted electronically via the RRB's Employer Reporting System (ERS) to employers. ERS consists of a series of screens with completion <span class=\"match\">instructions</span> and collects essentially the same information as the approved manual version. Form G-88A.1 is used for the <span class=\"match\">specific</span> purpose of verifying information previously provided"},{"title":"Phasedown of Hydrofluorocarbons: Review and Renewal of Eligibility for Application-Specific Allowances","type":"Rule","abstract":"The U.S. Environmental Protection Agency (EPA) is finalizing, pursuant to the statutory framework established in the American Innovation and Manufacturing Act of 2020 (AIM Act), the eligibility of six applications to continue to receive priority access to allowances to produce or import hydrofluorocarbons. In this final rule, EPA establishes the framework for how EPA interprets the statutory criteria for assessing whether to renew the eligibility of applications to receive application-specific allowances and sets out determinations to renew or not renew each of the six applications that currently receive application-specific allowances. EPA is also finalizing revisions to the Technology Transitions regulations relevant to the specific applications under review, a procedural process for submitting a petition to designate a new application as eligible for priority access to allowances, the methodology used to allocate allowances to application-specific allowance holders for calendar years 2026 and beyond, and limited revisions to existing regulations. In addition, EPA is authorizing an entity to produce regulated substances for export. Lastly, EPA is finalizing certain regulatory confidentiality determinations for newly reported information.","document_number":"2025-16357","html_url":"https://www.federalregister.gov/documents/2025/08/26/2025-16357/phasedown-of-hydrofluorocarbons-review-and-renewal-of-eligibility-for-application-specific","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-08-26/pdf/2025-16357.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-16357.pdf?1756125933","publication_date":"2025-08-26","agencies":[{"raw_name":"ENVIRONMENTAL PROTECTION AGENCY","name":"Environmental Protection Agency","id":145,"url":"https://www.federalregister.gov/agencies/environmental-protection-agency","json_url":"https://www.federalregister.gov/api/v1/agencies/145","parent_id":null,"slug":"environmental-protection-agency"}],"excerpts":"of applications to receive application-<span class=\"match\">specific</span> allowances and sets out determinations to renew or not renew each of the six applications that currently receive application-<span class=\"match\">specific</span> allowances. EPA is also finalizing revisions to the Technology Transitions regulations relevant to the <span class=\"match\">specific</span> applications under review, a procedural process for <span class=\"match\">submitting</span> a petition to designate a new application as eligible for priority access to allowances, the methodology used to allocate allowances to application-<span class=\"match\">specific</span> allowance holders for calendar years 2026"},{"title":"International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Effectiveness of Anthelmintics: Specific Recommendations for Caprines; Guidance for Industry; Availability","type":"Notice","abstract":"The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry (GFI) #97 entitled \"Effectiveness of Anthelmintics: Specific Recommendations for Caprines.\" This guidance has been developed for veterinary use by the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH). The objective of this guidance is to provide study design recommendations specific to caprines that will facilitate the universal acceptance of the generated effectiveness data to fulfill the national/regional requirements for anthelmintic drugs in animal species.","document_number":"2026-12681","html_url":"https://www.federalregister.gov/documents/2026/06/24/2026-12681/international-cooperation-on-harmonisation-of-technical-requirements-for-registration-of-veterinary","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-06-24/pdf/2026-12681.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-12681.pdf?1782218715","publication_date":"2026-06-24","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"Written/Paper Submissions \n <span class=\"match\">Submit</span> written/paper submissions as follows: \n \n • \n Mail/Hand Delivery/Courier (for written/paper submissions): \n Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.\n \n • For written/paper comments <span class=\"match\">submitted</span> to the Dockets Management Staff, FDA will post your comment, as well as any attachments, except for information <span class=\"match\">submitted</span>, marked and identified, as confidential, if <span class=\"match\">submitted</span> as detailed in “<span class=\"match\">Instructions</span>.” \n \n <span class=\"match\">Instructions</span>: \n All submissions received"},{"title":"International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Effectiveness of Anthelmintics: Specific Recommendations for Felines; Guidance for Industry; Availability","type":"Notice","abstract":"The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry (GFI) #113 entitled \"Effectiveness of Anthelmintics: Specific Recommendations for Felines.\" This guidance has been developed for veterinary use by the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH). The objective of this guidance is to provide study design recommendations specific to felines that will facilitate the universal acceptance of the generated effectiveness data to fulfill the national/regional requirements for anthelmintic drugs in animal species.","document_number":"2026-12685","html_url":"https://www.federalregister.gov/documents/2026/06/24/2026-12685/international-cooperation-on-harmonisation-of-technical-requirements-for-registration-of-veterinary","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-06-24/pdf/2026-12685.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-12685.pdf?1782218716","publication_date":"2026-06-24","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"Written/Paper Submissions \n <span class=\"match\">Submit</span> written/paper submissions as follows: \n \n • \n Mail/Hand Delivery/Courier (for written/paper submissions): \n Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.\n \n • For written/paper comments <span class=\"match\">submitted</span> to the Dockets Management Staff, FDA will post your comment, as well as any attachments, except for information <span class=\"match\">submitted</span>, marked and identified, as confidential, if <span class=\"match\">submitted</span> as detailed in “<span class=\"match\">Instructions</span>.” \n \n <span class=\"match\">Instructions</span>: \n All submissions received"},{"title":"International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Effectiveness of Anthelmintics: Specific Recommendations for Equines; Guidance for Industry; Availability","type":"Notice","abstract":"The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry (GFI) #109 entitled \"Effectiveness of Anthelmintics: Specific Recommendations for Equines.\" This guidance has been developed for veterinary use by the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH). The objective of this guidance is to provide study design recommendations specific to equines that will facilitate the universal acceptance of the generated effectiveness data to fulfill the national/regional requirements for anthelmintic drugs in animal species.","document_number":"2026-12682","html_url":"https://www.federalregister.gov/documents/2026/06/24/2026-12682/international-cooperation-on-harmonisation-of-technical-requirements-for-registration-of-veterinary","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-06-24/pdf/2026-12682.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-12682.pdf?1782218716","publication_date":"2026-06-24","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"Written/Paper Submissions \n <span class=\"match\">Submit</span> written/paper submissions as follows: \n \n • \n Mail/Hand Delivery/Courier (for written/paper submissions): \n Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.\n \n • For written/paper comments <span class=\"match\">submitted</span> to the Dockets Management Staff, FDA will post your comment, as well as any attachments, except for information <span class=\"match\">submitted</span>, marked and identified, as confidential, if <span class=\"match\">submitted</span> as detailed in “<span class=\"match\">Instructions</span>.” \n \n <span class=\"match\">Instructions</span>: \n All submissions received"},{"title":"International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Effectiveness of Anthelmintics: Specific Recommendations for Canines; Guidance for Industry; Availability","type":"Notice","abstract":"The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry (GFI) #111 entitled \"Effectiveness of Anthelmintics: Specific Recommendations for Canines.\" This guidance has been developed for veterinary use by the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH). The objective of this guidance is to provide study design recommendations specific to canines that will facilitate the universal acceptance of the generated effectiveness data to fulfill the national/regional requirements for anthelmintic drugs in animal species.","document_number":"2026-12684","html_url":"https://www.federalregister.gov/documents/2026/06/24/2026-12684/international-cooperation-on-harmonisation-of-technical-requirements-for-registration-of-veterinary","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-06-24/pdf/2026-12684.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-12684.pdf?1782218716","publication_date":"2026-06-24","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"Written/Paper Submissions \n <span class=\"match\">Submit</span> written/paper submissions as follows: \n \n • \n Mail/Hand Delivery/Courier (for written/paper submissions): \n Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.\n \n • For written/paper comments <span class=\"match\">submitted</span> to the Dockets Management Staff, FDA will post your comment, as well as any attachments, except for information <span class=\"match\">submitted</span>, marked and identified, as confidential, if <span class=\"match\">submitted</span> as detailed in “<span class=\"match\">Instructions</span>.” \n \n <span class=\"match\">Instructions</span>: \n All submissions received"}]}